Briacell TherapeuticsBCTX
13F holders, Q1 2024 (March 31)1holders
$2.83avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings. The largest holder was Rosenberg Matthew Hamilton ($34).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 10778Y302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
Ownership 1 holders
| Rosenberg Matthew Hamilton | 0.00% | No change | 12 | $34 |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.